Ignite Creation Date:
2024-10-25 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06619613
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
A Study of CM383 in Patients With Alzheimers Disease Related Mild Cognitive Impairment and Mild Alzheimers Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Double-blind Placebo-controlled and Multiple Dose Escalation Phase Ib Study Evaluating the Safety Tolerability Pharmacokinetics Pharmacodynamics and Immunogenicity of CM383 in Patients With Alzheimers Disease Related Mild Cognitive Impairment and Mild Alzheimers Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind placebo-controlled and multiple dose escalation phase Ib study evaluating the safety tolerability pharmacokinetics pharmacodynamics and immunogenicity of CM383 in patients with Alzheimers disease related mild cognitive impairment and mild Alzheimers disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None